Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSB2400026	Risankizumab注射液（ABBV-066）	risankizumab	Injection	Biological Products(2.2)	Supplementary Application	2024-03-09		AbbVie Biotechnology Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG;Abbvie Inc			view
JXSB2300056	Risankizumab注射液（ABBV-066）	risankizumab	Injection	Biological Products(2.2)	Supplementary Application	2023-05-16		Patheon Italia SpA;Abbvie Inc			view
JXSB2300057	Risankizumab注射液（ABBV-066）	risankizumab	Injection	Biological Products(2.2)	Supplementary Application	2023-05-16		Boehringer Ingelheim Pharma Gmbh & Co KG;Abbvie Inc			view
JXSB2300058	Risankizumab注射液（ABBV-066）	risankizumab	Injection	Biological Products(2.2)	Supplementary Application	2023-05-16		Boehringer Ingelheim Pharma Gmbh & Co KG;Abbvie Inc			view
JXSB2101107	Risankizumab注射液（ABBV-066）	risankizumab	Injection	Biological Products(2.2)	Supplementary Application	2021-12-10		Boehringer Ingelheim Pharma Gmbh & Co KG;Abbvie Inc			view
JXSB2101108	Risankizumab注射液（ABBV-066）	risankizumab	Injection	Biological Products(2.2)	Supplementary Application	2021-12-10		Boehringer Ingelheim Pharma Gmbh & Co KG;Abbvie Inc			view
JXSL1800064	Risankizumab注射液（ABBV-066）	risankizumab	Injection	Biological Products	Import Drug Application	2018-12-14	AbbVie Inc.	Abbvie Inc	In Review	2018-12-13	view
JXSL1800067	Risankizumab注射液（ABBV-066）300mg/3.33mL	risankizumab	Injection	Biological Products	Import Drug Application	2018-12-14	AbbVie Inc.	Abbvie Inc	In Review	2018-12-13	view
JXSL1800066	Risankizumab注射液（ABBV-066）	risankizumab	Injection	Biological Products	Import Drug Application	2018-12-14	AbbVie Inc.	Abbvie Inc	In Review	2018-12-13	view
JXSL1800065	Risankizumab注射液（ABBV-066）	risankizumab	Injection	Biological Products	Import Drug Application	2018-12-14	AbbVie Inc.	Abbvie Inc	In Review	2018-12-13	view
JXSL1800063	Risankizumab注射液（ABBV-066）	risankizumab	Injection	Biological Products	Import Drug Application	2018-12-10	AbbVie Inc.	Abbvie Inc	In Review	2018-12-08	view